In the beginning of the year in 2002 a bio-pharmaceutical company was founded in Cranbury, New Jersey. That company is called Amicus Therapeutics which also has roughly one hundred employees currently working for it. Amicus Therapeutics and in the year 2007 Amicus went public and started trading on the NASDAQ Under the symbol FOLD (YahooFinance). With steady growth Amicus Therapeutics opened a second location in San Diego, California. So with two locations on both coasts Amicus Therapeutics will have its focus on the main goal of the company which deals with rare and orphan diseases with particular disorders called lysosomal storage disorders.
With the saying “WE ARE PASSIONATE ABOUT WHAT WE DO”, this global biotechnological company is at the forefront of helping patients with Fabry Disease,Pompe Disease and others. The onset of Fabry Disease will shorten a persons life at approximately by fifty years. Pompe Disease is a lysosomal storage disorder which is diagnosed shortly after the birth of a child which includes the enlargement of the heart and muscle weakness. The late onset of Pompe Disease will not appear until late childhood or early adulthood. It is known that Pompe Disease affects aproximately 5,000 to 10,000 people worldwide.
Amicus Therapeutics is at the forefront of helping patients and their families with their dedication of helping with its services just beyond these horrible diseases. They listen and learn from the patients and families that are affected by these diseases. Amicus is always looking for better ways to help those afflicted by those diseases. Give information and the resources for families to fight the disease that one of their family members suffer with. At this time Amicus is in the middle of developing processes to help families cope with these terrible diseases. Amicus also wants to be involved in the education and support of families cope with these devastating diseases.
Facebook | Twitter | Crunchbase
For jobs with Amicus Therapeutics visit Indeed